Hieff Trans™ UltraProFect Transfection Reagent _ 40830ES

YeasenSku: 40830ES01

Size: 100 μL
Precio:
Precio de venta$65.00

Envío calculado En caja

Existencias:
En stock

Descripción

The Hieff TransTM UltraProFect Transfection Reagent is a highly efficient transfection reagent designed specifically for protein expression, primarily used for transient transfection and protein production in CHO and 293 suspension systems. It combines the powerful capability of rapid, ultra-high yield transient protein production in suspension culture with the exceptional advantages of CHO and 293 cell expression systems. This transfection reagent is meticulously designed for high-density CHO and 293 suspension cultures, significantly enhancing protein expression outcomes.

In various CHO cell lines (including expiCHO, CHO-S, CHO-K1, etc.) and 293 cell lines (expi293, 293F, etc.), this transfection reagent achieves highly efficient protein expression. It meets the preparation needs of complex proteins such as antigen proteins, cytokines, monoclonal antibodies, nanobodies, and bispecific antibodies. It significantly improves expression efficiency and yield, fulfilling protein production requirements across diverse application scenarios.

Features

Broader Compatibility

Supports both CHO and 293 transient expression systems.

Superior Yield

Delivers approximately 2-fold higher protein expression yields compared to leading brands.

Versatile Applications

Capable of producing a wide range of complex proteins, including antigen proteins, cytokines, monoclonal antibodies, nanobodies, and bispecific antibodies.

Specifications

Cat.No.

40830ES01 / 40830ES03 / 40830ES10 / 40830ES60

Size

100 μL / 1 mL / 10 mL / 100 mL

Components

Name

40830ES01

40830ES03

40830ES10

40830ES60

UltraProFect Transfection Reagent

100 μL

1 mL

10 mL

100 mL

Storage

Store at 2~8°C, protected from light. Valid for 1 year.

Figure

Case Studies: Transient Expression in CHO Cell Lines

(A) . Monoclonal Antibody Expression Comparison


(B) 
. Nanobody Expression Comparison


(C). Bispecific Antibody(BsAb) Expression Comparison

Figure 1. Performance comparison of Yeasen’s CHO Protein Expression Kit vs. leading brands in antibody yield, cell viability, and cell density.

 Figure 1. Performance comparison of Yeasen’s CHO Protein Expression Kit vs. leading brands in antibody yield, cell viability, and cell density.

Cell line: ExpiCHO, initial transfection density: 6×10⁶ cells/mL. Yeasen’s Hieff TransTM UltraPRO-CHO Transfection Reagent Kit achieves comparable antibody titers, cell viability, and cell growth profiles to leading brand reagents across full-length monoclonal antibodies, nanobodies, and bispecific antibodies, demonstrating robust and reliable performance for high-yield protein production.

 

Case Studies: Transient Expression in 293 Cell Lines

(A). Antigen-Fc Expression Comparison


(B). Antigen-His Expression Comparison


(C). Antibody Expression Comparison

Figure 2. Performance comparison of Yeasen’s UltraPRO-293 Transient Transfection Kit vs. leading brands in antibody and antigen expression.

Figure 2. Performance comparison of Yeasen’s UltraPRO-293 Transient Transfection Kit vs. leading brands in antibody and antigen expression.

Cell line: Expi293; initial transfection density: 4×10⁶ cells/mL; expression monitored over 7 days. Yeasen’s Hieff Trans™ UltraPRO-293 Transient Transfection Kit enables efficient expression of antibodies, antigen-Fc, and antigen-His proteins, delivering 2–3 times higher protein yield than leading brands while meeting diverse application needs. 

Documents:

Safety Data Sheet

40830_MSDS_HB260422

Manuals

40830_Manual_Ver.EN20260421

Pago y seguridad

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

Su información de pago se procesa de forma segura. No almacenamos detalles de la tarjeta de crédito ni tenemos acceso a la información de su tarjeta de crédito.

También te puede gustar

Consulta

Preguntas frecuentes

El producto es solo para fines de investigación y no está destinado a uso terapéutico o diagnóstico en humanos o animales. Los productos y el contenido están protegidos por patentes, marcas comerciales y derechos de autor propiedad de Yeasen Biotechnology. Los símbolos de marca comercial indican el país de origen, no necesariamente el registro en todas las regiones.

Algunas aplicaciones pueden requerir derechos de propiedad intelectual adicionales de terceros.

Yeasen se dedica a la ciencia ética y cree que nuestra investigación debe abordar cuestiones críticas al tiempo que garantiza la seguridad y los estándares éticos.